Randall Shultz is CTO at Arcadia Biosciences, Inc. (RKDA). They have made 1 open-market trade across 1 company since 2020, most recently 2020-08-03.
CIK 0001808500
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RKDA | 13,000 | $2K |
Shares reported on the most recent Form 4, priced at the 2021-01-25 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RKDA | BUY | 2020-08-03 | 2021-01-25 | $3.16 | $2K | +9.9% | +6.7% | -10.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.